Humacyte HUMA Cash Flow Statement (2020-2026)

NASDAQ HUMA
$0.41 +0.01 (+1.28%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

Humacyte Quarterly Cash Flow Statement

Periods 24 quarters
Latest Jun 2026

Humacyte reported cash from operations of -$22.10M and free cash flow of -$22.20M for the quarter ended Jun 2026, up 16.3% year over year. This cash flow statement covers 24 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-31.56M42.59M-19.83M36.87M-25.28M-3.72M-36.97M-22.71M-26.00M-25.11M-31.90M-56.66M-39.20M-20.94M39.14M-37.66M-17.51M-24.80M-17.62M-36.80M
Depreciation and DepletionDep. & Depletion
1.50M1.50M1.53M1.50M1.50M1.60M1.60M1.50M1.30M1.36M1.30M1.30M1.30M1.29M1.31M1.30M1.30M1.33M1.34M1.34M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.52M0.52M0.52M0.51M0.52M0.52M0.52M0.52M0.52M0.52M0.52M0.52M0.52M0.52M0.52M0.52M0.52M0.45M0.45M0.45M
Depreciation & Amortization (CF)Dep. & Amort.
1.50M1.50M1.53M1.50M1.50M1.60M1.60M1.50M1.30M1.36M1.30M1.30M1.30M1.29M1.31M1.30M1.30M1.33M1.34M1.34M
Share-based CompensationStock Comp.
1.88M2.81M1.55M1.49M1.48M1.67M1.81M1.84M1.77M1.41M1.45M1.44M1.55M1.69M2.49M2.43M2.36M3.13M3.17M2.61M
Gains from Sales and DivestituresGains Divest
-0.01M-0.01M0.00M
Gains from Investment SecuritiesGains Investment
0.23M-0.07M-0.04M-0.06M-0.14M-0.03M0.06M-0.39M1.05M3.20M14.93M-0.75M4.01M20.57M8.53M-5.16M
Other non-cash itemsOther Non-Cash
9.80M-65.60M-3.36M-56.40M1.00M-17.52M14.20M-1.21M1.14M-1.67M4.61M25.57M8.49M-5.59M-49.72M5.47M-4.89M20.85M-3.11M2.72M
Change in Working Capital
Change in ReceivablesChange Receivables
-0.45M-0.06M0.06M1.07M-1.27M-0.03M0.31M-0.09M0.68M-0.64M-0.01M-0.10M
Change in InventoryChange Inventory
8.02M2.95M7.30M3.56M-2.04M-2.27M
Change in Account PayablesChange Payables
-0.01M-0.95M0.93M-0.56M0.61M-1.49M0.30M0.47M0.53M3.52M-2.95M2.31M1.11M-2.44M0.65M1.49M2.99M-4.16M-0.36M-0.91M
Change in Accured ExpensesChange Accured Exp.
0.88M-0.37M-1.30M0.73M1.77M-0.96M-0.60M-0.13M3.30M-0.41M-2.11M1.89M2.20M0.26M-2.27M-0.14M0.96M-0.26M-2.18M0.69M
Change in Other Operating AssetsOther Assets Change
1.93M0.17M-0.82M-0.15M0.16M-0.55M-0.12M3.78M-3.24M-0.04M-0.41M0.13M-0.11M0.31M-0.39M-0.11M0.06M0.97M1.44M0.86M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.02M-0.02M
Other Working Capital ChangesOther WC Changes
-1.94M-0.18M0.81M0.14M-0.17M0.54M0.11M-3.79M3.22M0.02M0.40M-0.14M0.10M-0.32M0.38M0.10M-0.08M-0.97M-1.44M-0.86M
Cash from OperationsCash from Ops.
-30.52M-21.46M-18.80M-16.60M-16.80M-18.93M-18.64M-22.60M-13.06M-19.01M-27.35M-21.29M-22.91M-26.58M-28.60M-26.41M-23.90M-26.12M-25.10M-22.10M
Investing Activities
Capital ExpendituresCapex
0.08M0.05M0.02M0.13M0.21M0.68M1.15M0.49M0.49M0.15M0.39M0.18M0.93M0.06M0.23M0.57M0.05M0.04M0.18M0.10M
Change in Property, Plant and EquipmentChange in PP&E
-0.08M-0.05M-0.02M-0.13M-0.21M-0.68M-1.15M-0.49M-0.49M-0.15M-0.39M-0.18M-0.93M-0.06M-0.23M-0.57M-0.05M-0.04M-0.18M-0.10M
Purchase of InvestmentsInvestments Purchased
8.00M2.11M
Sale and Maturity of InvestmentsInvestments Sold
8.00M
Cash from Investing ActivitiesCash from Investing
-0.08M-8.05M-0.02M-0.13M-0.21M5.21M-1.15M1.62M-0.49M-0.15M-0.39M-0.18M-0.93M-0.06M-0.23M-0.57M-0.05M-0.04M-0.18M-0.10M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
10.00M39.46M20.00M0.24M0.18M
Long-Term Debt RepaymentsLT Debt Repayment
0.44M0.45M0.46M0.50M0.51M0.52M0.53M32.06M0.58M0.59M0.60M0.64M0.66M0.67M0.69M0.73M50.74M38.60M0.17M
Non-Current Debt
-0.44M9.55M-0.46M-0.50M-0.52M-0.53M7.39M-0.59M19.40M-0.40M-0.66M-0.67M-0.69M-0.73M-50.74M-38.42M-0.17M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.44M9.55M-0.46M-0.50M-0.52M-0.53M7.39M-0.59M19.40M-0.40M-0.66M-0.67M-0.69M-0.73M-50.74M-38.42M-0.17M
Change in Capital Stock
Common Stock IssuedStock Issued
242.76M0.00M0.00M0.01M0.22M0.31M0.12M0.10M0.10M0.25M0.00M0.79M0.50M0.23M0.06M0.01M0.03M
Shares Repurchased
Net Shares Issued and RepurchasedNet Shares Issued
242.76M0.00M0.00M0.01M0.22M0.31M0.12M0.10M0.10M0.25M0.00M0.79M0.50M0.23M0.06M0.01M0.03M
Net Equity Issued and RepurchasedNet Equity Issued
242.76M0.00M0.00M0.01M0.22M0.31M0.12M0.10M0.10M0.25M0.00M0.79M0.50M0.23M0.06M0.01M0.03M
Other financing activitiesOther financing
-0.24M-3.00M-0.30M-0.29M-0.77M
Cash from Financing ActivitiesCash from Financing
242.08M6.55M-0.46M-0.48M-0.29M-0.21M-0.41M6.02M-0.76M-0.34M62.80M-0.47M0.85M51.01M46.74M2.17M-44.59M57.17M23.32M53.53M
Additional items
Change in Cash
211.48M-22.95M-19.28M-17.19M-17.30M-13.96M-20.20M-14.97M-14.26M-19.54M35.06M-21.94M-22.99M24.37M17.91M-24.82M-68.54M31.01M-1.96M31.36M
Ending Cash Balance
240.45M217.50M198.22M181.04M163.73M149.77M129.57M114.60M100.34M80.80M115.86M93.92M70.92M95.29M113.20M88.39M19.84M
Free Cash FlowFCF
-30.60M-21.50M-18.82M-16.73M-17.01M-19.61M-19.79M-23.09M-13.55M-19.16M-27.74M-21.48M-23.84M-26.64M-28.83M-26.98M-23.95M-26.16M-25.28M-22.20M
Net Cash FlowNCF
211.48M-22.96M-19.28M-17.22M-17.30M-13.93M-20.20M-14.97M-14.31M-19.49M35.06M-21.94M-22.99M24.37M17.91M-24.82M-68.54M31.01M-1.96M31.33M
Interest Paid
0.38M0.48M0.56M0.60M0.70M0.80M0.88M0.73M

Humacyte Cash Flow Statement API

Pull Humacyte's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=HUMA&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY